阿卡迪亚(ACAD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACAD 阿卡迪亚

交易中 02-05 12:58:20 EST

23.99

-0.24

-0.99%

最高24.67	最低23.92	成交量32.12万
今开24.50	昨收24.23	日振幅3.12%
总市值40.59亿	流通市值27.79亿	总股本1.69亿
成交额776.59万	换手率0.28%	流通股本1.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACAD","market":"US","secType":"STK","nameCN":"阿卡迪亚","latestPrice":23.99,"timestamp":1770314291381,"preClose":24.23,"halted":0,"volume":321196,"delay":0,"changeRate":-0.009905076351630293,"floatShares":115846212,"shares":169181817,"eps":1.541283,"marketStatus":"交易中","change":-0.24,"latestTime":"02-05 12:58:20 EST","open":24.5,"high":24.67,"low":23.915,"amount":7765948.514707999,"amplitude":0.03116,"askPrice":24.04,"askSize":137,"bidPrice":23.99,"bidSize":304,"shortable":3,"etf":0,"ttmEps":1.541283,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770325200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1085630400000,"exchange":"NASDAQ","adjPreClose":24.23,"preHourTrading":{"tag":"盘前","latestPrice":24.49,"preClose":24.23,"latestTime":"09:29 EST","volume":1607,"amount":38947.981578,"timestamp":1770301799999,"change":0.26,"changeRate":0.01073,"amplitude":0.050764},"postHourTrading":{"tag":"盘后","latestPrice":24.23,"preClose":24.23,"latestTime":"16:45 EST","volume":29848,"amount":723199.585,"timestamp":1770241503366,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.435455,"impliedVol":0.3634,"impliedVolPercentile":0.4024},"requestUrl":"/m/hq/s/ACAD","defaultTab":"news","newsList":[{"id":"1123797841","title":"ACADIA Pharmaceuticals 就欧盟地区Rett综合征治疗药物Trofinetide的监管申报进展提供更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1123797841","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123797841?lang=zh_cn&edition=full","pubTime":"2026-02-03 05:05","pubTimestamp":1770066315,"startTime":"0","endTime":"0","summary":"阿卡迪亚制药公司近日公布了其治疗Rett综合征的药物Trofinetide在欧盟地区监管申报的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4139","LU2065170008.USD","LU2065171402.SGD","LU2065169927.USD","ACAD"],"gpt_icon":0},{"id":"2603614651","title":"阿卡迪亚医疗保健盘中异动 下午盘急速跳水5.14%报12.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603614651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603614651?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:11","pubTimestamp":1768327877,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日02时11分，阿卡迪亚医疗保健股票出现异动，股价大幅下挫5.14%。截至发稿，该股报12.55美元/股，成交量112.227万股，换手率1.24%，振幅5.52%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体涨幅为0.01%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。在美国，急性住院精神病设施和专科治疗设施为阿卡迪亚贡献了绝大部分的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011402111797a1aacf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011402111797a1aacf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACHC","LU2065170008.USD","BK4185","BK4139","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","ACAD"],"gpt_icon":0},{"id":"1190727234","title":"阿卡迪亚制药在第44届摩根大通医疗健康大会上公布业务与研发管线最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1190727234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190727234?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:04","pubTimestamp":1768313090,"startTime":"0","endTime":"0","summary":"在第44届摩根大通年度医疗健康大会上，阿卡迪亚制药（ACADIA Pharmaceuticals）向与会者详细介绍了公司当前的核心业务状况以及研发管线的关键更新。此次汇报涵盖了公司战略重点、在研项目进展以及未来发展方向，展现了公司在神经科学领域的持续投入与创新布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","ACAD","LU2065171311.SGD"],"gpt_icon":0},{"id":"1167008921","title":"阿卡迪亚制药公司 - Daybue Stix 将在2026年第一季度以有限方式上市，并在2026年第二季度早期更广泛上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1167008921","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167008921?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:03","pubTimestamp":1765544599,"startTime":"0","endTime":"0","summary":"阿卡迪亚制药公司 - Daybue Stix 将在2026年第一季度以有限方式上市，并在2026年第二季度早期更广泛上市","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4139","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","ACAD"],"gpt_icon":0},{"id":"1111703233","title":"阿卡迪亚制药宣布FDA批准Daybue® Stix（Trofinetide）作为口服溶液，用于治疗雷特综合症的新粉末配方","url":"https://stock-news.laohu8.com/highlight/detail?id=1111703233","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111703233?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:01","pubTimestamp":1765544490,"startTime":"0","endTime":"0","summary":"阿卡迪亚制药宣布FDA批准Daybue® Stix（Trofinetide）作为口服溶液，这是一种用于治疗雷特综合症的新型粉末配方。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU2065170008.USD","BK4139","LU2065171402.SGD","LU2065169927.USD","ACAD"],"gpt_icon":0},{"id":"2586322942","title":"阿卡迪亚医疗保健盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586322942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586322942?lang=zh_cn&edition=full","pubTime":"2025-11-27 00:32","pubTimestamp":1764174752,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日00时32分，阿卡迪亚医疗保健股票出现异动，股价大幅拉升5.07%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体涨幅为0.11%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。在美国，急性住院精神病设施和专科治疗设施为阿卡迪亚贡献了绝大部分的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127003233a4bc36f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127003233a4bc36f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065171311.SGD","ACAD","LU2065169927.USD","ACHC","LU2065170008.USD","BK4185","BK4139"],"gpt_icon":0},{"id":"2581020740","title":"阿卡迪亚盘中异动 早盘大幅跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581020740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581020740?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:41","pubTimestamp":1762440062,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时41分，阿卡迪亚股票出现波动，股价大幅跳水5.19%。截至发稿，该股报21.17美元/股，成交量10.2628万股，换手率0.06%，振幅10.84%。阿卡迪亚股票所在的生物技术行业中，整体涨幅为0.06%。阿卡迪亚公司简介：阿卡迪亚制药有限公司是一家生物制药公司，专注于解决中枢神经系统疾病和罕见疾病未满足的医疗需求的药物的开发和商业化。公司在神经科学和神经罕见疾病方面有两个核心特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622410294f3843b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110622410294f3843b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACAD","BK4139","LU2065171402.SGD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD"],"gpt_icon":0},{"id":"2579170311","title":"阿卡迪亚医疗保健盘中异动 快速跳水5.00%报21.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579170311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579170311?lang=zh_cn&edition=full","pubTime":"2025-10-31 03:45","pubTimestamp":1761853515,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日03时45分，阿卡迪亚医疗保健股票出现异动，股价急速跳水5.00%。截至发稿，该股报21.86美元/股，成交量107.711万股，换手率1.17%，振幅4.72%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体跌幅为0.53%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。在美国，急性住院精神病设施和专科治疗设施为阿卡迪亚贡献了绝大部分的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031034516a47e62a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031034516a47e62a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065171311.SGD","BK4139","LU2065170008.USD","LU2065169927.USD","BK4185","ACAD","ACHC"],"gpt_icon":0},{"id":"2576707278","title":"阿卡迪亚盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576707278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576707278?lang=zh_cn&edition=full","pubTime":"2025-10-17 02:19","pubTimestamp":1760638774,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日02时19分，阿卡迪亚股票出现波动，股价快速下跌5.01%。截至发稿，该股报20.65美元/股，成交量146.433万股，换手率0.87%，振幅6.65%。阿卡迪亚股票所在的生物技术行业中，整体涨幅为0.51%。阿卡迪亚公司简介：阿卡迪亚制药有限公司是一家生物制药公司，专注于解决中枢神经系统疾病和罕见疾病未满足的医疗需求的药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017021934a6bd7159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017021934a6bd7159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU2065169927.USD","BK4139","LU2065170008.USD","LU2065171402.SGD","ACAD"],"gpt_icon":0},{"id":"1151381917","title":"ACADIA Pharmaceuticals盘前大跌13% 罕见病疗法在后期试验中未达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1151381917","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151381917?lang=zh_cn&edition=full","pubTime":"2025-09-24 19:40","pubTimestamp":1758714017,"startTime":"0","endTime":"0","summary":"ACADIA Pharmaceuticals股价在盘前交易中下跌13%，该公司罕见病治疗药物在后期临床试验中未能达到主要研究终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4139","ACAD","LU2065169927.USD","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"1162573436","title":"ACADIA Pharmaceuticals Inc：鼻喷催产素的安全性和耐受性概况与此前临床试验结果一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1162573436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162573436?lang=zh_cn&edition=full","pubTime":"2025-09-24 19:03","pubTimestamp":1758711814,"startTime":"0","endTime":"0","summary":"ACADIA Pharmaceuticals Inc：鼻喷催产素的安全性和耐受性概况与此前临床试验结果一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065171402.SGD","LU2065169927.USD","ACAD","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"1148540901","title":"阿卡迪亚制药公司宣布鼻喷卡贝托辛（ACP-101）治疗普拉德-威利综合征食欲亢进的3期Compass PWS试验未达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1148540901","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148540901?lang=zh_cn&edition=full","pubTime":"2025-09-24 19:01","pubTimestamp":1758711705,"startTime":"0","endTime":"0","summary":"阿卡迪亚制药公司宣布，其针对普拉德-威利综合征食欲亢进症状的鼻喷卡贝托辛（ACP-101）3期Compass PWS临床试验未能达到主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","ACAD","LU2065170008.USD","LU2065169927.USD","BK4139","LU2065171311.SGD"],"gpt_icon":0},{"id":"2568472046","title":"阿卡迪亚医疗保健盘中异动 下午盘大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568472046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568472046?lang=zh_cn&edition=full","pubTime":"2025-09-18 02:05","pubTimestamp":1758132300,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日02时05分，阿卡迪亚医疗保健股票出现波动，股价大幅上涨5.07%。截至发稿，该股报22.81美元/股，成交量180.28万股，换手率1.95%，振幅4.88%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体涨幅为0.91%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。在美国，急性住院精神病设施和专科治疗设施为阿卡迪亚贡献了绝大部分的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918020500a726bd67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918020500a726bd67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4185","ACHC","LU2065169927.USD","BK4139","LU2065171402.SGD","LU2065170008.USD","ACAD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2567107753","title":"阿卡迪亚盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567107753?lang=zh_cn&edition=full","pubTime":"2025-09-16 02:24","pubTimestamp":1757960657,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日02时24分，阿卡迪亚股票出现异动，股价急速拉升5.04%。截至发稿，该股报24.80美元/股，成交量144.084万股，换手率0.85%，振幅5.08%。机构评级方面，在所有20家参与评级的机构中，65%的券商给予买入建议，30%的券商给予持有建议，5%的券商给予卖出建议。阿卡迪亚股票所在的生物技术行业中，整体涨幅为0.10%。公司在神经科学和神经罕见疾病方面有两个核心特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916022417a4c7e52f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916022417a4c7e52f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4139","LU2065170008.USD","LU2065171402.SGD","LU2065169927.USD","ACAD"],"gpt_icon":0},{"id":"2566916044","title":"阿卡迪亚医疗保健盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566916044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566916044?lang=zh_cn&edition=full","pubTime":"2025-09-11 22:55","pubTimestamp":1757602549,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日22时55分，阿卡迪亚医疗保健股票出现波动，股价急速上涨5.01%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体涨幅为0.77%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。消息层面，截至22时55分，《美银证券下调阿卡迪亚医疗保健至持有评级，下调目标价至25美元》资讯为影响阿卡迪亚医疗保健的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911225549a4c13872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911225549a4c13872&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACHC","LU2065170008.USD","LU2065171311.SGD","ACAD","BK4139","LU2065169927.USD","BK4185","LU2065171402.SGD"],"gpt_icon":0},{"id":"1188451578","title":"阿卡迪亚制药公司根据纳斯达克上市规则5635(C)(4)报告诱导性授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1188451578","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188451578?lang=zh_cn&edition=full","pubTime":"2025-09-09 04:50","pubTimestamp":1757364628,"startTime":"0","endTime":"0","summary":"9月8日，ACADIA Pharmaceuticals Inc宣布根据纳斯达克上市规则5635(C)(4)报告诱导性授予。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","ACAD","BK4139"],"gpt_icon":0},{"id":"1130555779","title":"ACADIA Pharmaceuticals任命Konstantina Katcheves为高级副总裁兼首席业务和战略官","url":"https://stock-news.laohu8.com/highlight/detail?id=1130555779","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130555779?lang=zh_cn&edition=full","pubTime":"2025-08-26 04:09","pubTimestamp":1756152556,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACAD","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2561236156","title":"阿卡迪亚医疗保健盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561236156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561236156?lang=zh_cn&edition=full","pubTime":"2025-08-22 22:53","pubTimestamp":1755874417,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日22时53分，阿卡迪亚医疗保健股票出现波动，股价大幅上涨5.00%。截至发稿，该股报22.49美元/股，成交量24.2983万股，换手率0.26%，振幅5.18%。阿卡迪亚医疗保健股票所在的医疗设施行业中，整体涨幅为0.45%。阿卡迪亚医疗保健公司简介：阿卡迪亚医疗保健公司收购并开发行为健康护理设施。在美国，急性住院精神病设施和专科治疗设施为阿卡迪亚贡献了绝大部分的收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822225337a6f5c89f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822225337a6f5c89f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065169927.USD","ACAD","BK4139","LU2065170008.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2558263681","title":"阿卡迪亚医疗保健2025财年第二财季实现净利润30.13百万美元，同比减少61.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558263681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558263681?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841719,"startTime":"0","endTime":"0","summary":"8月11日，阿卡迪亚医疗保健公布财报，公告显示公司2025财年第二财季净利润为30.13百万美元，同比减少61.61%；其中营业收入为8.69亿美元，同比增加9.17%，每股基本收益为0.33美元。机构评级：截至2025年8月11日，当前有14家机构对阿卡迪亚医疗保健目标价做出预测，其中目标均价为33.21美元，其中最低目标价为20.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000451a4805840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000451a4805840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACAD","ACHC"],"gpt_icon":1},{"id":"2517301994","title":"阿卡迪亚医疗保健2024财年实现净利润2.56亿美元，同比增加1281.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517301994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517301994?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:01","pubTimestamp":1741363261,"startTime":"0","endTime":"0","summary":"3月8日，阿卡迪亚医疗保健公布财报，公告显示公司2024财年净利润为2.56亿美元，同比增加1281.36%；其中营业收入为31.54亿美元，同比增加7.68%，每股基本收益为2.79美元。从资产负债表来看，阿卡迪亚医疗保健总负债27.66亿美元，其中短期债务1.03亿美元，资产负债比为2.16，流动比率为1.00。机构评级：截至2025年3月8日，当前有13家机构对阿卡迪亚医疗保健目标价做出预测，其中目标均价为48.31美元，其中最低目标价为35.00美元，最高目标价为72.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000307abed672a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000307abed672a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACHC","ACAD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acadia.com","stockEarnings":[{"period":"1week","weight":-0.0543},{"period":"1month","weight":-0.0734},{"period":"3month","weight":0.1192},{"period":"6month","weight":-0.015},{"period":"1year","weight":0.2936},{"period":"ytd","weight":-0.0928}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acadia Pharmaceuticals Inc.于1993年在佛蒙特州成立，是一家生物制药公司，专注于创新型微分子药物的研发和商业化，以解决在神经系统和中枢神经系统疾病上未满足的医疗需求。公司有一系列候选产品，以pimavanserin为首，该产品处于第三开发阶段，可用于治疗帕金森综合症。公司已成功完成关键的第三阶段试验，公司计划于2014年底向美国食品药品管理局提交新药申请。Pimavanserin处于老年痴呆症治疗研发的第二阶段，并已成功完成第二阶段的试验，可以作为老年痴呆症的协同治疗手段。公司的产品还包括与Allergan合作的慢性疼痛和青光眼临床阶段项目，以及两个先进的用于治疗帕金森综合症和其他神经系统疾病的临床项目。公司所有的候选产品和项目都是来自于企业内部研发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.058102},{"month":2,"riseRate":0.636364,"avgChangeRate":0.022729},{"month":3,"riseRate":0.428571,"avgChangeRate":0.056582},{"month":4,"riseRate":0.428571,"avgChangeRate":0.000567},{"month":5,"riseRate":0.571429,"avgChangeRate":0.061282},{"month":6,"riseRate":0.5,"avgChangeRate":-0.015184},{"month":7,"riseRate":0.590909,"avgChangeRate":0.052638},{"month":8,"riseRate":0.545455,"avgChangeRate":0.014715},{"month":9,"riseRate":0.5,"avgChangeRate":0.023984},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.024848},{"month":11,"riseRate":0.454545,"avgChangeRate":0.031974},{"month":12,"riseRate":0.545455,"avgChangeRate":0.059204}],"exchange":"NASDAQ","name":"阿卡迪亚","nameEN":"ACADIA Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿卡迪亚(ACAD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿卡迪亚(ACAD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿卡迪亚,ACAD,阿卡迪亚股票,阿卡迪亚股票老虎,阿卡迪亚股票老虎国际,阿卡迪亚行情,阿卡迪亚股票行情,阿卡迪亚股价,阿卡迪亚股市,阿卡迪亚股票价格,阿卡迪亚股票交易,阿卡迪亚股票购买,阿卡迪亚股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿卡迪亚(ACAD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿卡迪亚(ACAD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}